Elevance Health (ELV) closed at $394.48 on November 20, 2026, up 1.1% from the previous close, on volume of 1,739,582 shares (30-day average 1,447,229).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 5, 2026 | Diagonal Put Spread | 18-Dec-26 : 19-Mar-27340 : 270 P | 460 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 19, 2026. See the largest for 5, 30, 60 and 90 days
50 Russell 1000 stocks mutual funds love most - Goldman
Seeking Alpha News (Fri, 20-Nov 11:33 AM ET)
Health insurers extend slide amid ‘Medicare for All’ push
Seeking Alpha News (Thu, 19-Nov 12:36 PM ET)
Bernstein Reaffirms Their Buy Rating on Elevance Health (ELV)
TipRanks (Thu, 19-Nov 5:56 AM ET)
TipRanks (Wed, 18-Nov 1:29 PM ET)
Biggest stock movers Tuesday: Managed care stocks, ACM, RCAT, and more
Seeking Alpha News (Tue, 17-Nov 9:51 AM ET)
Managed care drops as U.S. seeks crackdown on Medicare, Medicaid fraud
Seeking Alpha News (Tue, 17-Nov 8:32 AM ET)
Business Wire (Tue, 17-Nov 8:00 AM ET)
Alnylam tops healthcare earnings surprise list, ahead of Regeneron and Eli Lilly
Seeking Alpha News (Tue, 17-Nov 6:08 AM ET)
Glenview ups stakes in Meta, Teva; cuts CVS, Block in Q3; exits DKS, STM
Seeking Alpha News (Tue, 17-Nov 5:18 AM ET)
Elevance Health (ELV) Receives a Buy from Mizuho Securities
TipRanks (Mon, 16-Nov 11:15 AM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of November 20, 2026, ELV stock price climbed to $394.48 with 1,739,582 million shares trading.
ELV has a beta of 0.71, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.08 to the broad based SPY ETF.
ELV has a market cap of $85.55 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $50 billion in Revenue and $6.99 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $2.30.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VOO, VTI, IVV, SPY, VTV.
ELV has outperformed the market in the last year with a return of +26.9%, while the SPY ETF gained +5.2%. In the last 3 month period, ELV beat the market returning -0.6%, while SPY returned -10.1%. However, in the most recent 2 weeks ELV has underperformed the stock market by returning -8.7%, while SPY returned -5.9%.
ELV support price is $380.67 and resistance is $399.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.